Edison, NJ -- (SBWIRE) -- 02/05/2019 -- A new independent 100 page research with title 'Global Smoking Cessation and Nicotine De-addiction Products Market (2017–2023)' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions like North America, Europe, Asia-Pacific, South America, Middle East and Africa and important players/vendors such as NJOY, CIPLA, Johnson & Johnson, GlaxoSmithKline etc. With n-number of tables and figures examining the Global Smoking Cessation and Nicotine De-addiction Products Market, the research gives you a visual, one-stop breakdown of the leading products, submarkets and market leader's market revenue forecasts as well as analysis to 2022

Request a sample report @ https://www.htfmarketreport.com/sample-report/1610196-global-smoking-cessation-and-nicotine-de-addiction-products-market-5

Summary
Smoking cessation and nicotine de-addiction products are devices and therapies used for treating symptoms associated with the discontinuation of nicotine consumption. According to the World Health Organization (WHO), tobacco kills around 6 Mn people each year globally, of which, almost 5 Mn deaths are because of direct tobacco use. Nicotine also causes critical ailments like cardiovascular diseases, cancer, etc. Owing to the detrimental effects of tobacco on health, governments in developed countries are encouraging smokers to refrain from consuming tobacco products. The global smoking cessation and nicotine de-addiction products market is expected to expand at a compound annual growth rate (CAGR) of 20.2%, leading to a global revenue of USD 39.51 Bn by 2023, from USD 15.77 Bn in 2018.

Products segment insights:
The global nicotine replacement therapy (NRT) market had the lowest market share (about 16%) in 2018, mainly due to the reluctance to adopt smoking cessation products, and lack of awareness about nicotine de-addiction products. On the other hand, the e-cigarettes segment is anticipated to expand at a higher CAGR of 22.0% during the forecasted period (2018-2023). This high growth can be attributed to e-cigarettes' ability to replicate the same sensation as smoking a conventional cigarette while minimizing the health risks associated with the latter. The increasing adoption of e-cigarettes is because of the availability of a variety of flavors and nicotine concentrations.

Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/1610196-global-smoking-cessation-and-nicotine-de-addiction-products-market-5

Regional insights:
The Americas have been leading the market with its innovations in smoking cessation products, and account for approximately 42% of the global market. However, Asia-Pacific is expected to have the highest growth rate during the forecast period due to high tobacco consumption in this region, coupled with rising disposable income.

Companies covered:
NJOY, CIPLA, Johnson & Johnson, GlaxoSmithKline, Pfizer, Imperial Brands PLC, Nicotek, LLC., Japan Tobacco Inc.

Place a Purchase Order for this Market Study (Single User License) at: https://www.htfmarketreport.com/buy-now?format=1&report=1610196

Chapter 1: Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered in this study
1.3. Executive summary

Chapter 2: Global smoking cessation and nicotine de-addiction products market - overview
2.1. Global market overview – trends, market attractiveness analysis, and geography-wise market revenue (USD Bn)
2.2. Market drivers and challenges
2.3. Value chain analysis
2.4. Porter's five forces analysis
2.5. Market size based on products (nicotine replacement therapy [NRT] and e-cigarettes)
2.5. a. NRT - historical
....Continued

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/1610196-global-smoking-cessation-and-nicotine-de-addiction-products-market-5

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.